Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Shareholders of Kimberly-Clark will own about 54% of the combined company. Kenvue shareholders will own about 46% in what is one of the largest corporate takeovers this year.

The combined company will have a huge stable of household brands under one roof, putting Kenvue’s Listerine mouthwash and Band-Aid side-by-side with Kimberly-Clark’s Cottonelle toilet paper, Huggies and Kleenex tissues…

  • seitzer@piefed.social
    link
    fedilink
    English
    arrow-up
    111
    ·
    3 days ago

    So, the whole autism-tylenol-theater was to beat down the price of the company? Because that’s what it smells like.

      • Bakkoda@sh.itjust.works
        link
        fedilink
        English
        arrow-up
        7
        ·
        2 days ago

        It’s the only angle for the people at the top. If you constantly ask what’s the point you need to keep thinking about who could benefit. It’s always a business or a person grifting the US of A.